Drugs / Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02770248 | May 2016 → Jan 2017 | glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02770248 ↗ |